The Georgetown professor isn't a toy lover—he's trying to convey a philosophical idea about the nature of free will and the capacity of humans to remake the world around them.
Markets work if you let them. The Biden administration and Congress should remove supply restraints on baby formula that never made any sense in the first place.
Plus: Supreme Court sides with Ted Cruz in campaign finance case, gender quota for corporate boards ruled unconstitutional, and more...
"The knot in getting that product into the U.S. isn't safety, it's a regulatory issue," says Peter Pitts.
Plus: Netflix defends artistic expression, perspectives on the baby formula shortage, and more...
Trade restrictions and over-zealous FDA regulation are a big part of the problem, but there's more.
The activists who say otherwise are wrong on the costs and wrong on the science.
Plus: Trusting the science is now an explicitly partisan issue, stocks are still plummeting, and more...
In a move that is likely to undermine public health, the agency warns that products containing synthetic nicotine "will be subject to FDA enforcement."
The proposed rule, which targets the cigarettes that black smokers overwhelmingly prefer, will harm the community it is supposed to help.
Menthols aren’t harder to quit than other cigarettes.
The Stanford professor and Great Barrington Declaration coauthor stands up to COVID-19 autocrats and disastrous lockdowns by following the science.
The anti-lockdown Stanford public health professor on being attacked by Fauci, the loss of trust in medical experts, and how to save science going forward.
Among experts on food safety, the consensus is that the FDA's food division isn't functional.
The agency's obsession with adolescent vaping is driving decisions that undermine public health.
The state's regulators plan to start accepting applications from manufacturers and "service centers" on January 2.
Meanwhile the FDA dawdles over second boosters as new COVID-19 wave approaches
It’s likely to happen any day now.
The experience in Texas shows that workarounds pose daunting obstacles to such laws.
A spending bill provision would redefine "tobacco products" to include products that have nothing to do with tobacco.
Robert Califf must demand transparency and accountability from the bureaucrats.
From the CDC to the FDA, there are too many missteps to list.
Not only won’t they blow your mind, but they may even save it (sometimes legally).
While the rule is set to go into effect this weekend, companies are scrambling to figure out how to cover or reimburse people for the tests.
Why? A better question was why they were ever involved in the first place.
One step closer to solving the organ shortage crisis?
Plus: Waiting lists for public defenders, inflation boogeymen, and more...
Plus: Questioning paranoia about smartphones and attention spans, new small business creation is thriving, and more...
It's another case of bureaucratic incompetence as the omicron wave surges.
Plus: Criminals have stolen $100 billion in pandemic relief funds, and colleges are planning to go virtual once again.
Federal regulators have permanently lifted a requirement that mifepristone be dispensed in person.
Bureaucratic foot-dragging is costing lives.
The omicron COVID-19 variant is likely to sweep through the country in the next month or so.
The justices show little interest in vaping regulation on the shadow docket, but may yet review the FDA's behavior in the regular course.
Pfizer/BioNTech reports that a third shot significantly neutralizes the emerging variant.
Plus: RIP to sex entrepreneur Phil Harvey, Elon Musk says Congress should can Biden's spending plan, and more....
Policy makers are acting as if saving the lives of smokers via harm-reducing alternatives counts for nothing.
While the press and politicians try to make the virus a political morality play, Reason keeps its head even while screaming at anti-scientific restrictionism.
The same agency that stymied COVID-19 testing is now dawdling over approving new antiviral pills.
Vaping regulation gets some attention on the Shadow Docket
Vaccine makers are already targeting the omicron variant.
Instead of pining for authoritarian control, maybe U.S. health officials could tell the FDA to stop standing in the way of progress.
An electronic cigarette manufacturer seeks a stay of FDA action from the Supreme Court.
After months of inconsistent messaging and a chaotic track record, will anybody trust it?
In rejecting Breeze Smoke's application for a stay of the FDA's rejection of their product applications, the Sixth Circuit disagrees with the Fifth Circuit.
Do you care about free minds and free markets? Sign up to get the biggest stories from Reason in your inbox every afternoon.
This modal will close in 10
